{"id":249,"date":"2013-10-24T12:30:00","date_gmt":"2013-10-24T12:30:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=earnings-remain-strong-with-solid-return-on-capital"},"modified":"2013-10-24T12:30:00","modified_gmt":"2013-10-24T12:30:00","slug":"earnings-remain-strong-with-solid-return-on-capital","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/fr\/mfn_news\/earnings-remain-strong-with-solid-return-on-capital\/","title":{"rendered":"Earnings remain strong with solid return on capital"},"content":{"rendered":"
Nolato reports sustained strong earnings and a solid return on capital in its Q3 2013 interim report released today. Group sales rose by 12% to SEK 1,119 million (999), with operating profit (EBITA) up 23% to SEK 103 million (84). Earnings per share for the past 12-month period rose to SEK 11.25 (6.70).<\/strong><\/div>\n

\u201cWe\u2019re very pleased indeed that our strong performance continued in the third quarter,\u201d says President and CEO of Nolato, Hans Porat.<\/span><\/p>\n

Sales of the Nolato Medical business area rose 8% to SEK 310 million (288), which was well in line with market growth. Operating profit (EBITA) increased to SEK 41 million (32), and the EBITA margin rose to 13.2% (11.1). <\/span><\/p>\n

\u201cMost of the business area\u2019s customer segments enjoyed solid volumes,\u201d says Hans Porat. \u201cThe margin was positively affected by a favourable product mix.\u201d <\/span><\/p>\n

Sales of the Nolato Telecom business area rose 16% to SEK 516 million (444). Operating profit (EBITA) totalled SEK 35 million (35), with an EBITA margin of 6.8% (7.9). <\/span><\/p>\n

\u201cThe gradual renewal of the product portfolio in the second half of the year, with a slightly higher proportion of materials, affected the margin,\u201d comments Hans Porat. <\/span><\/p>\n

Sales of the Nolato Industrial business area rose 9% to SEK 293 million (268). Operating profit (EBITA) climbed to SEK 33 million (24), and the EBITA margin to a very strong 11.3% (9.0). <\/span><\/p>\n

\u201cVolumes were stable and during the holiday period, there was higher demand this year than in the same period last year. Combined with high productivity and a favourable product mix, this gave a positive effect on the margin,\u201d says Hans Porat. <\/span><\/p>\n

Nolato\u2019s Board resolved at its meeting today on the extension of the Hungarian factory by a further 3,700 square metres in order to enable further future expansion. <\/span><\/p>\n

Nolato\u2019s financial position remains strong. Return on capital employed for the past 12-month period was 25.5% (17.8). Net debt stood at SEK 75 million (323), with an equity\/assets ratio of 45% (43). <\/span><\/p>\n

The year-end report for 2013 will be released on 4 February 2014. <\/span><\/p>\n

The AGM will be held on 28 April 2014. <\/span><\/p>\n

———
For further information, please contact:
Hans Porat, President and CEO, +46 (0)705 517550
Per-Ola Holmstr\u00f6m, CFO, +46 (0)705 763340 <\/span><\/p>\n

Nolato is a high-tech developer and manufacturer of polymer products for leading customers in medical technology, telecommunications, hygiene, automotive and other selected industrial sectors. <\/span><\/em><\/p>\n

Its B shares are listed on the NASDAQ OMX Stockholm. Nolato is a Mid Cap company in the Industrials sector. <\/span><\/em><\/p>\n

www.nolato.com <\/span><\/em><\/a><\/p>\n

The information is such which Nolato AB is obliged to disclose under the Swedish Securities Market Act and\/or the Swedish Financial Instruments Trading Act. This information was made public on 24 October 2013 at 2.30 pm.<\/span><\/em><\/p>\n

\n

<\/strong><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nolato reports sustained strong earnings and a solid return on capital in its Q3 2013 interim report released today. Group sales rose by 12% to SEK 1,119 million (999), with operating profit (EBITA) up 23% to SEK 103 million (84). Earnings per share for the past 12-month period rose to SEK 11.25 (6.70).<\/p>\n","protected":false},"template":"","class_list":["post-249","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-report-interim-q3","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"fr","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":true},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/mfn_news\/249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/fr\/wp-json\/wp\/v2\/media?parent=249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}